Arbutus Biopharma Corp Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)
Arbutus Biopharma Corp (ABUS) had Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) of $11.79 million as of 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:LiabilitiesFairValueDisclosureRecurring · last filed 2018-05-04
- 2018-03-31: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $11.79M.
- 2017-12-31: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $11.66M.
- 2017-09-30: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $12.03M.
- 2017-06-30: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $11.00M.
| Period end | Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) |
|---|---|
| 2018-03-31 | $11.79M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $11.66M 10-Q · filed 2018-05-04 |
| 2017-09-30 | $12.03M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $11.00M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $10.94M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $9.72M 10-K · filed 2018-03-16 |
| 2016-09-30 | $9.50M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $9.61M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $10.22M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $8.38M 10-K · filed 2017-03-22 |
| 2015-09-30 | $8.16M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $8.74M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $10.36M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $5.10M 10-K · filed 2016-03-09 |
| 2014-09-30 | $8.71M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $6.59M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |